[17] [18] The magnitude of benefit appears closely related to the degree of weight loss achieved
Daily Dose: 2.67 mg (equivalent to 10 units / 0.10 mL), maintained throughout the full cycle Frequency: Administer once daily via subcutaneous injection, ideally at the same time each day Cycle Duration: 4-16 weeks of continuous use, followed by a 24 week break to assess response and support receptor recovery Injection Volume: Approximately 0.10 mL per dose, well within typical comfort limits for subcutaneous delivery (generally under 1.01.5 mL) Syringe Guidance: A 0.3 mL (30-unit) U-100 insulin syringe is recommended for improved accuracy when measuring small volumes Storage Instructions Proper storage is essential to maintain peptide stability and integrity
We prioritize this level of testing for every product we create, as it is the only way to truly earn the trust of our community
Caught between a desire to be thin and strong urges to eat more food, weight suppression could trap people in cycles of bingeing and purging. WHY IT MATTERS The study highlights the concept of weight suppression the difference between a persons highest and current weight and how it affects hormone levels
Endurance Blocks: Combine BPC157 with MOTSc during deload weeks to promote mitochondrial repair
The molecular structure and basic chemistry of BPC-157 are documented below